Specifically, under hypoxic conditions, Jag2 upregulates NOX2 expression, which leads to the increased expression of proinflammatory factors and elevated oxidative stress levels, inhibits PASMC apoptosis, and promotes PASMC proliferation and migration, ultimately contributing to vascular remodeling in the PAH rat model. Here, JAG2 is linked to pulmonary arterial hypertension.